skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Efficacy of Preoperative Transcatheter Arterial Embolization for Nasopharyngeal Angiofibroma: A Comparative Study

Abstract

ObjectiveThis study aimed to retrospectively evaluate the efficacy and safety of preoperative transcatheter arterial embolization (pTAE) for treating nasopharyngeal angiofibroma (NPAF).MethodsSeventy-four NPAF patients were hospitalized for elective surgical treatment with pTAE (pTAE group, n = 32) or surgical treatment alone (non-pTAE group, n = 42) between January 1990 and December 2013. The following outcome measures were retrospectively analyzed and compared: intraoperative bleeding volume, surgery time (ST), duration of postoperative hospital stay (PHS), and disease recurrence.ResultsAmong Radkowski stage I patients, those in pTAE group had a slightly higher but not significant bleeding volume than patients in non-pTAE group (344 ± 407 vs. 248 ± 219 mL, P = 0.899); among stage II/III patients, however, patients in pTAE group showed a significantly lower bleeding volume than patients in non-pTAE group (stage II, 829 ± 519 vs. 1339 ± 767 mL, P = 0.035; stage III, 1267 ± 592 vs. 2125  ± 479 mL, P = 0.024). The two groups presented comparable OTs, PHSs, and rates of frontal recurrence (all P>0.05).ConclusionspTAE significantly reduces intraoperative bleeding in NPAF patients with Radkowski stage II/III disease, but offers no additional benefits regarding ST, PHS, or recurrence.

Authors:
;  [1];  [2];  [1];  [3]; ; ;  [1]
  1. The First Affiliated Hospital of Sun Yat-sen University, Department of Interventional Radiology (China)
  2. The First Affiliated Hospital of Sun Yat-sen University, Department of Clinical Laboratory (China)
  3. The First Affiliated Hospital of Sun Yat-sen University, Department of Nuclear Medicine (China)
Publication Date:
OSTI Identifier:
22645172
Resource Type:
Journal Article
Resource Relation:
Journal Name: Cardiovascular and Interventional Radiology; Journal Volume: 40; Journal Issue: 6; Other Information: Copyright (c) 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; COMPARATIVE EVALUATIONS; HOSPITALS; PATIENTS; SAFETY; SURGERY; VASCULAR DISEASES

Citation Formats

Tan, Guosheng, Ma, Zhenjiang, Long, Weiqing, Liu, Liangshuai, Zhang, Bing, Chen, Wei, Yang, Jianyong, and Li, Heping, E-mail: jxgdhp@163.com. Efficacy of Preoperative Transcatheter Arterial Embolization for Nasopharyngeal Angiofibroma: A Comparative Study. United States: N. p., 2017. Web. doi:10.1007/S00270-017-1587-3.
Tan, Guosheng, Ma, Zhenjiang, Long, Weiqing, Liu, Liangshuai, Zhang, Bing, Chen, Wei, Yang, Jianyong, & Li, Heping, E-mail: jxgdhp@163.com. Efficacy of Preoperative Transcatheter Arterial Embolization for Nasopharyngeal Angiofibroma: A Comparative Study. United States. doi:10.1007/S00270-017-1587-3.
Tan, Guosheng, Ma, Zhenjiang, Long, Weiqing, Liu, Liangshuai, Zhang, Bing, Chen, Wei, Yang, Jianyong, and Li, Heping, E-mail: jxgdhp@163.com. Thu . "Efficacy of Preoperative Transcatheter Arterial Embolization for Nasopharyngeal Angiofibroma: A Comparative Study". United States. doi:10.1007/S00270-017-1587-3.
@article{osti_22645172,
title = {Efficacy of Preoperative Transcatheter Arterial Embolization for Nasopharyngeal Angiofibroma: A Comparative Study},
author = {Tan, Guosheng and Ma, Zhenjiang and Long, Weiqing and Liu, Liangshuai and Zhang, Bing and Chen, Wei and Yang, Jianyong and Li, Heping, E-mail: jxgdhp@163.com},
abstractNote = {ObjectiveThis study aimed to retrospectively evaluate the efficacy and safety of preoperative transcatheter arterial embolization (pTAE) for treating nasopharyngeal angiofibroma (NPAF).MethodsSeventy-four NPAF patients were hospitalized for elective surgical treatment with pTAE (pTAE group, n = 32) or surgical treatment alone (non-pTAE group, n = 42) between January 1990 and December 2013. The following outcome measures were retrospectively analyzed and compared: intraoperative bleeding volume, surgery time (ST), duration of postoperative hospital stay (PHS), and disease recurrence.ResultsAmong Radkowski stage I patients, those in pTAE group had a slightly higher but not significant bleeding volume than patients in non-pTAE group (344 ± 407 vs. 248 ± 219 mL, P = 0.899); among stage II/III patients, however, patients in pTAE group showed a significantly lower bleeding volume than patients in non-pTAE group (stage II, 829 ± 519 vs. 1339 ± 767 mL, P = 0.035; stage III, 1267 ± 592 vs. 2125  ± 479 mL, P = 0.024). The two groups presented comparable OTs, PHSs, and rates of frontal recurrence (all P>0.05).ConclusionspTAE significantly reduces intraoperative bleeding in NPAF patients with Radkowski stage II/III disease, but offers no additional benefits regarding ST, PHS, or recurrence.},
doi = {10.1007/S00270-017-1587-3},
journal = {Cardiovascular and Interventional Radiology},
number = 6,
volume = 40,
place = {United States},
year = {Thu Jun 15 00:00:00 EDT 2017},
month = {Thu Jun 15 00:00:00 EDT 2017}
}